INS and metabolic syndrome: In experiments by Osei-Hyiaman et al. (2008) [198], the selective deletion of hepatic CB1 receptors reduced the degree of hyperglycemia, dyslipidemia, and insulin and leptin resistance in mice with diet-induced obesity [198].